Flumazenil is a competitive GABAA receptor antagonist, used in the treatment of benzodiazepine overdoses.
|Solubility (25°C)||10 mM in DMSO|
Powder -20°C 3 years ; 4°C 2 years
In solvent -80°C 6 months ; -20°C 1 month
|Body Surface Area (m2)||0.007||0.025||0.15||0.05||0.02||0.5|
|Animal A (mg/kg) = Animal B (mg/kg) multiplied by||Animal B Km|
|Animal A Km|
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
 Hood SD, et al. Br J Clin Pharmacol. Benzodiazepine dependence and its treatment with low dose flumazenil.
|Related GABA Receptor Products|
Cenobamate (YKP-3089) is a novel antiepileptic agent with broad-spectrum anticonvulsant activity.
Afizagabar (S44819) is a first-in-class, competitive and selective α5-GABAAR antagonist with an IC50 value of 585 nM for α5β2γ2 and a Ki of 66 nM for α5β3γ2.
Pentetrazol (PTZ), a tetrazole derivative, is an inhibitor of gamma aminobutyric acid (GABAA) and its receptor complex. PTZ is a convulsive agent used to induce convulsions. It can penetrate the blood-brain barrier.
L-DAB HBR (L-Dab Hydrobromide, L-2,4-Diaminobutyric acid hydrobromide) is an inhibitor of GABA (Gamma-aminobutyric acid) transaminase with IC50 of >500 μM. L-DAB HBR exhibits antitumor activity.
Phenibut, a GABA analogue, is a central nervous system depressant with anxiolytic and sedative effects.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.